Search Results - "Seachrist, D"

Refine Results
  1. 1

    A review of the carcinogenic potential of bisphenol A by Seachrist, Darcie D., Bonk, Kristen W., Ho, Shuk-Mei, Prins, Gail S., Soto, Ana M., Keri, Ruth A.

    Published in Reproductive toxicology (Elmsford, N.Y.) (01-01-2016)
    “…The estrogenic properties of bisphenol A (BPA), a ubiquitous synthetic monomer that can leach into the food and water supply, have prompted considerable…”
    Get full text
    Journal Article
  2. 2

    The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer by Seachrist, Darcie D, Keri, Ruth A

    Published in Endocrinology (Philadelphia) (01-05-2019)
    “…Activins and inhibins are closely related protein heterodimers with a similar tissue distribution; however, these two complexes have opposing functions in…”
    Get full text
    Journal Article
  3. 3

    FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer by Seachrist, Darcie D., Anstine, Lindsey J., Keri, Ruth A.

    Published in Cancers (17-10-2021)
    “…The pioneering function of FOXA1 establishes estrogen-responsive transcriptomes in luminal breast cancer. Dysregulated FOXA1 chromatin occupancy through focal…”
    Get full text
    Journal Article
  4. 4
  5. 5

    UbcH7 regulates 53BP1 stability and DSB repair by Han, Xiangzi, Zhang, Lei, Chung, Jinsil, Pozo, Franklin Mayca, Tran, Amanda, Seachrist, Darcie D., Jacobberger, James W., Keri, Ruth A., Gilmore, Hannah, Zhang, Youwei

    “…DNA double-strand break (DSB) repair is not only key to genome stability but is also an important anticancer target. Through an shRNA library-based screening,…”
    Get full text
    Journal Article
  6. 6

    Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer by Seachrist, Darcie D, Sizemore, Steven T, Johnson, Emhonta, Abdul-Karim, Fadi W, Weber Bonk, Kristen L, Keri, Ruth A

    Published in Breast cancer research : BCR (05-06-2017)
    “…Follistatin (FST) is an intrinsic inhibitor of activin, a member of the transforming growth factor-β superfamily of ligands. The prognostic value of FST and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    HER2/ErbB2-induced Breast Cancer Cell Migration and Invasion Require p120 Catenin Activation of Rac1 and Cdc42[S] by Johnson, Emhonta, Seachrist, Darcie D., DeLeon-Rodriguez, Carlos M., Lozada, Kristen L., Miedler, John, Abdul-Karim, Fadi W., Keri, Ruth A.

    Published in The Journal of biological chemistry (17-09-2010)
    “…Breast cancers that overexpress the receptor tyrosine kinase ErbB2/HER2/Neu result in poor patient outcome because of extensive metastatic progression. Herein,…”
    Get full text
    Journal Article
  9. 9

    Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression by YORI, Jennifer L, LOZADA, Kristen L, SEACHRIST, Darcie D, MOSLEY, Jonathan D, ABDUL-KARIM, Fadi W, BOOTH, Christine N, FLASK, Chris A, KERI, Ruth A

    Published in Cancer research (Chicago, Ill.) (01-09-2014)
    “…Resistance to receptor tyrosine kinase (RTK) blockade in breast cancer is often mediated by activation of bypass pathways that sustain growth. Src and…”
    Get full text
    Journal Article
  10. 10

    LMO4 is an essential mediator of ErbB2 HER2 Neu-induced breast cancer cell cycle progression by Montañez-Wiscovich, M E, Seachrist, D D, Landis, M D, Visvader, J, Andersen, B, Keri, R A

    Published in Oncogene (15-10-2009)
    “…ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream…”
    Get full text
    Journal Article
  11. 11

    Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-β signaling in ErbB2/Neu-induced tumors from transgenic mice by LANDIS, Melissa D, SEACHRIST, Darcie D, MONTANEZ-WISCOVICH, Marjorie E, DANIELPOUR, David, KERI, Ruth A

    Published in Oncogene (04-08-2005)
    “…Upregulation of HER2/ErbB2/Neu occurs in 15-30% of human breast cancers and correlates with poor prognosis. Identification of ErbB2/Neu transcriptional targets…”
    Get full text
    Journal Article
  12. 12

    double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation by Peters, Gregory A, Seachrist, Darcie D, Keri, Ruth A, Sen, Ganes C

    “…PACT is a double-stranded RNA-binding protein that also binds and activates the latent protein kinase, PKR, which plays a major role in cellular antiviral…”
    Get full text
    Journal Article
  13. 13

    Krüppel-like Factor 4 Inhibits Tumorigenic Progression and Metastasis in a Mouse Model of Breast Cancer by Yori, Jennifer L, Seachrist, Darcie D, Johnson, Emhonta, Lozada, Kristen L, Abdul-Karim, Fadi W, Chodosh, Lewis A, Schiemann, William P, Keri, Ruth A

    Published in Neoplasia (New York, N.Y.) (01-07-2011)
    “…Abstract Krüppel-like factor 4 (KLF4) is a zinc finger transcription factor that functions as an oncogene or tumor suppressor in a highly tissue-specific…”
    Get full text
    Journal Article
  14. 14

    Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer by Mosley, Jonathan D, Poirier, John T, Seachrist, Darcie D, Landis, Melissa D, Keri, Ruth A

    Published in Molecular cancer therapeutics (01-08-2007)
    “…Amplification of the HER2 (ErbB2, c-Neu) proto-oncogene in breast cancer is associated with poor prognosis and high relapse rates. HER2/ErbB2, in conjunction…”
    Get full text
    Journal Article
  15. 15

    Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2 Neu-induced tumors by LANDIS, M. D, SEACHRIST, D. D, ABDUL-KARIM, F. W, KERI, R. A

    Published in Oncogene (01-06-2006)
    “…Epidemiological studies indicate that parity enhances HER2/ErbB2/Neu-induced breast tumorigenesis. Furthermore, recent studies using multiparous,…”
    Get full text
    Journal Article
  16. 16

    Chromatin Organization and Transcriptional Programming of Breast Cancer Cell Identity by Bobbitt, Jessica R, Seachrist, Darcie D, Keri, Ruth A

    Published in Endocrinology (Philadelphia) (01-08-2023)
    “…Abstract The advent of sequencing technologies for assessing chromosome conformations has provided a wealth of information on the organization of the…”
    Get full text
    Journal Article
  17. 17

    GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2) by Sizemore, Gina M., Sizemore, Steven T., Seachrist, Darcie D., Keri, Ruth A.

    Published in The Journal of biological chemistry (29-08-2014)
    “…Breast cancer is a heterogeneous disease comprised of distinct subtypes predictive of patient outcome. Tumors of the basal-like subtype have a poor prognosis…”
    Get full text
    Journal Article
  18. 18

    Reexpression of p8 Contributes to Tumorigenic Properties of Pituitary Cells and Appears in a Subset of Prolactinomas in Transgenic Mice that Hypersecrete Luteinizing Hormone by Mohammad, Helai P, Seachrist, Darcie D, Quirk, Christine C, Nilson, John H

    Published in Molecular endocrinology (Baltimore, Md.) (01-10-2004)
    “…Targeted overexpression of LH in transgenic mice causes hyperproliferation of Pit-1-positive pituitary cells and development of functional adenomas. To…”
    Get full text
    Journal Article
  19. 19

    Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer by Milliken, E L, Lozada, K L, Johnson, E, Landis, M D, Seachrist, D D, Whitten, I, Sutton, A L M, Abdul-Karim, F W, Keri, R A

    Published in Oncogene (13-03-2008)
    “…Aneuploidy and genomic instability are common features of human cancers, including breast cancer; however, mechanisms by which such abnormalities develop are…”
    Get full text
    Journal Article
  20. 20

    TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters by Webb, Bryan M., Bryson, Benjamin L., Williams-Medina, Eduardo, Bobbitt, Jessica R., Seachrist, Darcie D., Anstine, Lindsey J., Keri, Ruth A.

    Published in The Journal of biological chemistry (01-10-2021)
    “…Cyclin-dependent kinase 7 (CDK7) is a master regulatory kinase that drives cell cycle progression and stimulates expression of oncogenes in a myriad of…”
    Get full text
    Journal Article